Register for Postdocs & Researchers - Countagen - Internship project HT25

COUNTAGEN

Advancing Gene Therapy Safety with Next-Generation Genotyping Technology

Target Group : Postdocs & Researchers (3 months)

About Countagen

Join a pioneering biotech startup at the forefront of gene editing analysis technology. We are seeking a motivated postdoc to further validate and develop our breakthrough PCR-free platform that's set to transform how the field assesses cell & gene therapy safety.

The Project

You will be instrumental in further advancing our NGS-based technology to a market-ready solution, working directly with our founding team to establish this technology as the new standard for comprehensive gene editing characterization. This role offers unique exposure to both cutting-edge science and commercial biotech development.

Key Responsibilities

• Design and execute benchmarking studies comparing our technology to other sequencing-based methods
• Validate NGS library prep assay protocols for gene editing modalities with user cases
• Analyze NGS datasets and support development of quality control metrics
• Collaborate on project documentation and customer case studies
• Support early access program with academic, pharmaceutical and biotech partners

The Candidate

• PhD in molecular biology, genomics, or computational biology
• Track record of method development and optimization
• Interest in translating research into commercial applications
• Proficiency in NGS data analysis (e.g., Python, bioinformatics pipelines)
• Hands-on experience with gene editing technologies and gene editing workflows
• Experience in on- and off-target analysis (e.g., CRISPResso, rhAmpSeq, GUIDE-seq) - desired

Why Countagen

• Work with an ambitious team shaping the future of gene therapy development tools
• Experience the dynamic and exciting startup culture
• Collaborative environment where your contributions directly impact product direction
• Gain valuable experience in early-stage biotech commercialization

Desired Internship Period: November 1st – January 31st

Contact information

Name: Felix Neumann

Email: felix@countagen.com

Telephone: +46 722 691 740

Company website: www.countagen.com